Zevenbergen Capital Investments Has Boosted Stake in Lululemon Athletica (LULU); Crocs (CROX) Market Valuation Declined While North Run Capital LP Has Raised Its Holding

December 17, 2017 - By Henry Gaston

Thomas Ellis increased its stake in Crocs Inc (CROX) by 7.36% based on its latest 2017Q2 regulatory filing with the SEC. North Run Capital Lp bought 82,800 shares as the company’s stock declined 7.31% while stock markets rallied. The hedge fund run by Thomas Ellis held 1.21M shares of the consumer non-durables company at the end of 2017Q2, valued at $9.31M, up from 1.13 million at the end of the previous reported quarter. North Run Capital Lp who had been investing in Crocs Inc for a number of months, seems to be bullish on the $874.33M market cap company. The stock increased 14.72% or $1.61 during the last trading session, reaching $12.55. About 7.13M shares traded or 506.68% up from the average. Crocs, Inc. (NASDAQ:CROX) has declined 28.43% since December 17, 2016 and is downtrending. It has underperformed by 45.13% the S&P500.

Zevenbergen Capital Investments Llc increased its stake in Lululemon Athletica Inc. (LULU) by 16% based on its latest 2017Q2 regulatory filing with the SEC. Zevenbergen Capital Investments Llc bought 87,830 shares as the company’s stock declined 26.14% while stock markets rallied. The institutional investor held 636,825 shares of the apparel company at the end of 2017Q2, valued at $38.00M, up from 548,995 at the end of the previous reported quarter. Zevenbergen Capital Investments Llc who had been investing in Lululemon Athletica Inc. for a number of months, seems to be bullish on the $10.27 billion market cap company. The stock increased 1.39% or $1.04 during the last trading session, reaching $75.82. About 2.10M shares traded or 6.65% up from the average. Lululemon Athletica Inc. (NASDAQ:LULU) has declined 19.33% since December 17, 2016 and is downtrending. It has underperformed by 36.03% the S&P500.

Investors sentiment increased to 1.41 in Q2 2017. Its up 0.18, from 1.23 in 2017Q1. It is positive, as 17 investors sold CROX shares while 37 reduced holdings. 29 funds opened positions while 47 raised stakes. 61.39 million shares or 6.37% less from 65.57 million shares in 2017Q1 were reported. Schwab Charles Inv Mngmt Incorporated stated it has 0.01% in Crocs, Inc. (NASDAQ:CROX). Pacad Investment holds 0.03% or 29,761 shares in its portfolio. American Grp holds 55,437 shares or 0% of its portfolio. Metropolitan Life Insurance Company New York reported 52,668 shares stake. State Board Of Administration Of Florida Retirement Systems invested in 0% or 77,408 shares. Boston Ptnrs holds 697,739 shares or 0.01% of its portfolio. Goldman Sachs Group holds 143,391 shares or 0% of its portfolio. 14,247 are owned by Bluecrest Cap Mngmt Limited. Qs holds 76 shares. Grt Capital Prtnrs Ltd Com accumulated 17,000 shares. Public Sector Pension Board invested in 38,067 shares. Alliancebernstein LP holds 0.04% or 7.12M shares. Gp One Trading LP holds 53,512 shares or 0% of its portfolio. Moreover, State Of Alaska Department Of Revenue has 0.01% invested in Crocs, Inc. (NASDAQ:CROX) for 14,623 shares. Northern Tru Corp accumulated 980,005 shares.

Among 10 analysts covering Crocs (NASDAQ:CROX), 2 have Buy rating, 0 Sell and 8 Hold. Therefore 20% are positive. Crocs has $19 highest and $700 lowest target. $12.05’s average target is -3.98% below currents $12.55 stock price. Crocs had 23 analyst reports since August 11, 2015 according to SRatingsIntel. The firm has “Buy” rating by Stifel Nicolaus given on Friday, December 15. Susquehanna maintained Crocs, Inc. (NASDAQ:CROX) on Thursday, August 10 with “Hold” rating. Stifel Nicolaus maintained Crocs, Inc. (NASDAQ:CROX) rating on Thursday, October 1. Stifel Nicolaus has “Buy” rating and $16 target. The company was maintained on Thursday, July 13 by Piper Jaffray. B. Riley & Co maintained Crocs, Inc. (NASDAQ:CROX) rating on Thursday, October 1. B. Riley & Co has “Neutral” rating and $13 target. Robert W. Baird maintained the stock with “Hold” rating in Friday, October 20 report. The firm earned “Hold” rating on Monday, November 20 by C.L. King. The company was maintained on Wednesday, August 2 by Susquehanna. The firm earned “Hold” rating on Wednesday, April 27 by Stifel Nicolaus. The firm has “Neutral” rating given on Thursday, October 1 by Piper Jaffray.

North Run Capital Lp, which manages about $1.78 billion and $187.66 million US Long portfolio, decreased its stake in Imperva Inc (NYSE:IMPV) by 240,000 shares to 510,000 shares, valued at $24.40 million in 2017Q2, according to the filing. It also reduced its holding in Magnachip Semiconductor Corp (NYSE:MX) by 815,827 shares in the quarter, leaving it with 898,200 shares, and cut its stake in Constellium Nv (NYSE:CSTM).

Among 38 analysts covering Lululemon Athletica Inc. (NASDAQ:LULU), 22 have Buy rating, 1 Sell and 15 Hold. Therefore 58% are positive. Lululemon Athletica Inc. has $92 highest and $40 lowest target. $68.51’s average target is -9.64% below currents $75.82 stock price. Lululemon Athletica Inc. had 159 analyst reports since August 18, 2015 according to SRatingsIntel. Nomura maintained the shares of LULU in report on Thursday, March 31 with “Buy” rating. The firm earned “Neutral” rating on Thursday, February 2 by Goldman Sachs. Bank of America upgraded the shares of LULU in report on Thursday, December 8 to “Neutral” rating. The rating was maintained by Canaccord Genuity on Friday, June 2 with “Sell”. The firm has “Buy” rating by Nomura given on Thursday, March 30. Wolfe Research maintained the shares of LULU in report on Thursday, September 10 with “Peer Perform” rating. The firm has “Hold” rating given on Friday, September 2 by Canaccord Genuity. Needham maintained Lululemon Athletica Inc. (NASDAQ:LULU) rating on Thursday, December 7. Needham has “Buy” rating and $79.0 target. The stock of Lululemon Athletica Inc. (NASDAQ:LULU) has “Hold” rating given on Thursday, December 7 by Canaccord Genuity. The rating was maintained by FBR Capital on Thursday, December 10 with “Underperform”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: